Researchers analyzed the health records of more than 33,800 U.S. veterans diagnosed with non-melanoma skin cancer and found ...
This news could be tough to face. A new report from the Skin Cancer Foundation predicts that 234,680 cases of melanoma will ...
A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...
Reservations open next month for free skin cancer screenings through Penn State Health Dermatology at its Lime Spring ...
Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...
Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...
Moderna and Merck's melanoma vaccine, combined with Keytruda, could halve cancer recurrence risk, marking a breakthrough in ...
What if the earliest signs of skin cancer could be identified sooner—before a dermatology appointment?
By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized ...
After a routine skin check found basal cell carcinoma on her scalp, Stacia Naquin shares her story to stress early detection ...
“I’ll never forget going into a pharmacy and the woman behind the counter asking what the stains on my face were,” the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results